The Effect of Angiotensin Receptor-Neprilysin Inhibitor With Sodium-Glucose Cotransporter 2 Inhibitor versus Angiotensin Receptor-Neprilysin Inhibitor Without Sodium-Glucose Cotransporter 2 Inhibitor on Heart Failure Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

被引:0
作者
Kommu, Sharath
机构
关键词
Heart Failure; Angiotensin-Receptor Neprilysin Inhibitor (ARNI); Outcomes; Ejection fraction; Cardioprotective drugs;
D O I
10.1161/circ.148.suppl_1.12247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A12247
引用
收藏
页数:2
相关论文
共 50 条
[21]   The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review [J].
Ezhumalai, Babu ;
Modi, Ranjan ;
Panchanatham, Manokar ;
Kaliyamoorthy, Dhamodaran .
INDIAN HEART JOURNAL, 2024, 76 (04) :229-239
[22]   The Management Outcome of Heart Failure Reduced Ejection Fraction with or without Angiotensin Receptor Neprilysin Inhibitor [J].
Teng, W. J. ;
Suliman, A. S. Ali ;
Wyh, W. Isa .
IIUM MEDICAL JOURNAL MALAYSIA, 2024, 23 (04) :38-44
[23]   Efficacy of Sodium-Glucose Cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: An updated meta-analysis [J].
Yamani, Naser ;
Shaikh, Fahd Niaz ;
Sarfraz, Saba ;
Khan, Haider Kamal ;
Wasim, Muhammad Fahad ;
Paracha, Anousheh Awais ;
Almas, Talal ;
Mookadam, Farouk ;
Unzek, Samuel .
ANNALS OF MEDICINE AND SURGERY, 2021, 70
[24]   Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure [J].
Kambara, Takahiro ;
Shibata, Rei ;
Osanai, Hiroyuki ;
Nakashima, Yoshihito ;
Asano, Hiroshi ;
Murohara, Toyoaki ;
Ajioka, Masayoshi .
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2019, 13
[25]   Haemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients [J].
Nilsson, C. Noah ;
Ersboll, Mads Kristian ;
Gustafsson, Finn .
CARDIAC FAILURE REVIEW, 2024, 10
[26]   Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure [J].
Boehmer, Andreas A. ;
Schubert, Tim ;
Rothe, Moritz ;
Keim, Christoph ;
Wiedenmann, Lilli ;
Ruckes, Christian ;
von Stuelpnagel, Lukas ;
Theurl, Fabian ;
Schreinlechner, Michael ;
Dobre, Bianca C. ;
Kaess, Bernhard M. ;
Bauer, Axel ;
Ehrlich, Joachim R. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (15)
[27]   Effect of Angiotensin Receptor-neprilysin Inhibitor on Acute Kidney Injury in Patients With Acute Decompensated Heart Failure [J].
Li, Gonghao ;
Zhao, Yanli ;
Peng, Zhongxing ;
Liu, Kun ;
Yin, Delu ;
Zhao, Yunfeng .
CARDIOLOGY DISCOVERY, 2024, 4 (01) :23-29
[28]   Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects [J].
Kim, Donghyun ;
Jang, Gyuho ;
Hwang, Jaetaek ;
Wei, Xiaofan ;
Kim, Hyunsoo ;
Son, Jinbae ;
Rhee, Sang-Jae ;
Yun, Kyeong-Ho ;
Oh, Seok-Kyu ;
Oh, Chang-Myung ;
Park, Raekil .
PHARMACEUTICS, 2022, 14 (12)
[29]   Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure [J].
Jung, Mi-Hyang ;
Cho, Dong-Hyuk ;
Choi, Jimi ;
Kim, Mi-Na ;
Lee, Chan Joo ;
Son, Jung-Woo ;
Kim, Yaeni ;
Youn, Jong-Chan ;
Yoo, Byung-Su .
ESC HEART FAILURE, 2025,
[30]   Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care [J].
El Rafei, Abdelghani ;
Gosch, Kensey ;
Manning, Evan S. ;
Ghajar, Alireza ;
Raghavan, Sridharan ;
Maddox, Thomas M. ;
Peterson, Pamela N. ;
Fleming, Lisa ;
Arnold, Suzanne V. ;
Chan, Paul S. ;
Greene, Stephen J. ;
Fonarow, Gregg C. ;
Jones, Philip G. ;
Allen, Larry A. ;
Hess, Paul L. .
JAMA CARDIOLOGY, 2025,